Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Nabil A. Ali-Mros"'
Autor:
Francisco Hernández-Bernal, Maria C. Ricardo-Cobas, Yenima Martín-Bauta, Zadis Navarro-Rodríguez, Marjoris Piñera-Martínez, Joel Quintana-Guerra, Karen Urrutia-Pérez, Klaudia Urrutia-Pérez, Cristina O. Chávez-Chong, Jorge L. Azor-Hernández, José L. Rodríguez-Reinoso, Leonardo Lobaina-Lambert, Elizabeth Colina-Ávila, Jacqueline Bizet-Almeida, Jeniffer Rodríguez-Nuviola, Sergio del Valle-Piñera, Mayara Ramírez-Domínguez, Elisangela Tablada-Ferreiro, Marel Alonso-Valdés, Gilda Lemos-Pérez, Gerardo E. Guillén-Nieto, Ariel Palenzuela-Díaz, Enrique Noa-Romero, Miladys Limonta-Fernández, Juan M. Fernández-Ávila, Nabil A. Ali-Mros, Lianne del Toro-Lahera, Rossana Remedios-Reyes, Marta Ayala-Ávila, Verena L. Muzio-González
Publikováno v:
EClinicalMedicine, Vol 46, Iss , Pp 101383- (2022)
Summary: Background: Multiple vaccine candidates against COVID-19 are currently being evaluated. We evaluate the safety and immunogenicity protein of a novel SARS-CoV-2 virus receptor-binding domain (RBD) vaccine. Methods: A phase 1-2, randomised, do
Externí odkaz:
https://doaj.org/article/701e99cfcb8c4480864eb76aad6725f5
Autor:
Juan M. Fernández-Ávila, Jorge L. Azor-Hernández, Cristina O. Chávez-Chong, Klaudia Urrutia-Pérez, Lianne del Toro-Lahera, Joel Quintana-Guerra, Verena Muzio-Gonzalez, Enrique Noa-Romero, Yenima Martín-Bauta, Sergio del Valle-Piñera, Elisangela Tablada-Ferreiro, Rossana Remedios-Reyes, Gilda Lemos-Pérez, Zadis Navarro-Rodríguez, Marjoris Piñera-Martínez, Jacqueline Bizet-Almeida, Nabil A. Ali-Mros, Francisco Hernández-Bernal, Leonardo Lobaina-Lambert, Mayara Ramírez-Domínguez, José L. Rodríguez-Reinoso, Karen Urrutia-Pérez, Miladys Limonta-Fernández, Maria C. Ricardo-Cobas, Marel Alonso-Valdes, Ariel Palenzuela-Díaz, Marta Ayala-Ávila, Jeniffer Rodríguez-Nuviola, Elizabeth Colina-Ávila
AimTo evaluate the safety and immunogenicity of a SARS-CoV-2 recombinant spike protein vaccine (Abdala), administered intramuscularly in different strengths and vaccination schedules.MethodA phase 1-2, randomized, double-blind, placebo-controlled tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf87421192211cec367a7be6eaf1bd68
https://doi.org/10.1101/2021.11.30.21267047
https://doi.org/10.1101/2021.11.30.21267047
